October 2017

Journal-based learning for October

Each article’s contents should be read, researched and understood, and you should then come to a decision on each question. The pass mark is 17 out of 20 questions answered correctly. JBL exercises may be completed at any time until the published deadline date. Please select your choice of correct answers and complete the exercises online at: www.ibms.org/cpd/jbl

Science news in numbers: October

Diabetes

New prescribing data from NHS England shows in 2016:

"Injections cut heart attack risk"

Anti-inflammatory injections could lower the risk of heart attacks and may slow the progression of cancer. The researchers behind the claim say that their work may usher in a new era of preventative cardiology.

Chemo-boosting Drug

Drugs developed to treat heart and blood vessel problems could be used in combination with chemot

Under the microscope: MDMA

What is it MDMA?

To give it its full name – 3,4-methylenedioxymethamphetamine. It’s a synthetic “party drug” that alters moods and perception. It rose to prominence as part of the nightclub and rave scene.

Biomedical Systems Acquired

This enables ERT to further expand its ability to reduce customer risk and uncertainty when imagi

Indirect Carbapenemase test

Of increasing concern is the level of carbapenem resistance amongst Gram-negative bacteria caused

Here to help: reflective writing

An important part of the Institute’s qualifications and Continuing Professional Development (CPD)

My Lab: The patient-focused laboratory

Heart of England NHS Foundation Trust provides a wide range of services across East and North Bir

UK biomedical catalyst award

Centauri Therapeutics Ltd, a biotechnology company focused on the treatment of infectious diseases and cancer, has been awarded up to £945,000 under Innovate UK’s Biomedical Catalyst programme.

New method for lab-grown cells

Scientists from the University of Oxford have created a new method to 3D print laboratory-grown cells to form living structures.

Top